FCMI

Foresite Capital Management III Portfolio holdings

AUM $37.9M
1-Year Est. Return 6.87%
This Quarter Est. Return
1 Year Est. Return
-6.87%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$146M
AUM Growth
+$16.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
26
New
Increased
Reduced
Closed

Top Buys

1
+$16.3M
2
+$8.03M
3
+$6.83M
4
GBT
Global Blood Therapeutics, Inc.
GBT
+$3.21M
5
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$2.72M

Top Sells

1
+$9.14M
2
+$5.47M
3
+$3.3M
4
XENT
Intersect ENT, Inc
XENT
+$3.2M
5
LRMR icon
Larimar Therapeutics
LRMR
+$3.08M

Sector Composition

1 Healthcare 82.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$40M 27.42%
1,600,183
+321,613
2
$23.7M 16.25%
1,345,313
+388,187
3
$20.1M 13.77%
970,104
-441,645
4
$16.3M 11.19%
+763,688
5
$11.5M 7.86%
690,269
+193,269
6
$5.25M 3.6%
601,485
-46,855
7
$5.24M 3.6%
511,777
+35,000
8
$3.62M 2.48%
95,173
-73,022
9
$3.27M 2.25%
201,469
-90,902
10
$3.22M 2.21%
44,791
-42,779
11
$2.72M 1.87%
+15,000
12
$2.67M 1.83%
20,599
13
$2.66M 1.82%
9,854
-3,342
14
$2.54M 1.74%
235,020
-120,000
15
$1.09M 0.75%
254,258
-48,477
16
$920K 0.63%
17,802
-5,557
17
$895K 0.61%
+71,000
18
$166K 0.11%
70,177
-137,321
19
– –
-14,500
20
– –
-100,000
21
– –
-6,576
22
– –
-544,816
23
– –
-42,815
24
– –
-168,550
25
– –
-94,403
1
2